Viewing nowCombinationFosamax Plus Tablets
Sodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Granules 26.67mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.

MFDS item code 200511266 · Approved 2005.10.27 · Insurance code 073100290
Treatment of osteoporosis in postmenopausal women and men
This medication is used for the treatment of osteoporosis in postmenopausal women and men.
Take 1 tablet of this medicine once weekly (70 mg/2800 IU or 70 mg/5600 IU) in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see the General Precautions section). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reviewed regularly in all patients receiving bisphosphonates. Patients at low risk of fracture should consider discontinuing treatment after taking it for 3~5 years. Patients who discontinue treatment should have their fracture risk reviewed regularly. Other beverages or foods, including mineral water and barley tea, and medicines may reduce the absorption of alendronate (see the Interactions section). Consuming food within 30 minutes after taking this medicine, or at the same time, may reduce the absorption of alendronate into the body and decrease its effect. This medicine should be taken as soon as you get up in the morning, with plenty of water (170∼230 mL), to deliver the medicine rapidly to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it or until after the first food intake. Do not take this medicine at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see the Warnings and General Precautions sections). Patients with inadequate calcium and vitamin D intake from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, or patients with chronic illness) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine, taken once weekly, provides one week's supply of daily vitamin D at 400 IU and 800 IU. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. However, do not take 2 tablets on the same day. Administration in elderly patients (65 years of age or older): No dose adjustment is required. Administration in patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance of 35∼60 mL/min). However, use of this medicine is not recommended in patients with severe renal impairment (creatinine clearance below 35 mL/min), because clinical experience is insufficient.
Children and adolescents (under 18 years of age): Safety and efficacy in children and adolescents have not been established.
This medication can irritate the mucosa of the upper gastrointestinal tract, causing esophageal adverse reactions such as esophagitis, esophageal ulcers, and esophageal erosions. These symptoms may be accompanied by bleeding and can rarely lead to esophageal obstruction or perforation; therefore, if symptoms such as difficulty swallowing, pain during swallowing, pain behind the sternum, or heartburn appear, the patient should stop taking the medication immediately and consult a doctor. It is important to take the medication with a sufficient amount of water and not lie down for at least 30 minutes after taking it; maintaining an upright posture during administration is crucial. This medication should not be administered to patients with esophageal stricture or achalasia, those who cannot sit or stand upright for more than 30 minutes, patients with hypersensitivity to the ingredients, hypocalcemia patients, and those with lactose intolerance. While taking this drug, gastrointestinal symptoms such as abdominal pain, nausea, indigestion, constipation, diarrhea, acid reflux, esophagitis, or gastritis may occur, so it is advisable to inform healthcare professionals if these symptoms appear. Musculoskeletal pain, headaches, dizziness, and altered taste have also been reported as neurological and psychiatric adverse reactions, so caution is advised. In particular, since this medication aids in the absorption of calcium and vitamin D, taking supplements is recommended if calcium intake is insufficient. Older adults or chronic disease patients who are at high risk of vitamin D deficiency may need additional vitamin D supplementation. Women who are pregnant or nursing must consult a doctor regarding the use of this medication, and it is not to be used in children. In cases of overdose, hypocalcemia and gastrointestinal irritation symptoms may appear, so an immediate visit to a medical institution is required, and it is not appropriate to induce vomiting or attempt dialysis. There may be drug interactions when taking this medication, especially when taken with calcium supplements, antacids, aspirin, or nonsteroidal anti-inflammatory drugs, so caution is necessary. Lastly, this medication should be stored out of the reach of children, and transferring it to another container can negatively affect its quality.
esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, musculoskeletal pain, muscle cramps, headache, dizziness, taste disorder, rash, erythema, anastomotic ulcer, urticaria, angioedema, hypersensitivity reaction, myalgia, fatigue, asthenia, fever, symptoms of hypocalcemia, peripheral edema, esophageal stricture, oropharyngeal ulcer, gastric ulcer, duodenal ulcer, localized osteonecrosis of the jaw, joint swelling, low-grade fracture, dizziness, vertigo, itching, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal, nasopharyngitis
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is also important to avoid direct sunlight and store it at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness over time.
Oval-shaped tablet, white to grayish-white, with 710 engraved on one side and a bone picture on the other side.
4 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Granules 26.67mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Granules 53.33mg
Tablet · Prescription medication · Combination
Han-guk Organon Co., Ltd.
CombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Granules 53.33mg
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.